The India veterinary healthcare market is projected to register a CAGR of 7.98% during the forecast period, with a revenue of approximately USD 1,083.13 million in 2020 and expected to reach USD 1,697.15 million by 2026
The COVID-19 pandemic has been continuing to transform the growth of various markets, the immediate impact of the outbreak is varied. While a few industries registered a drop in demand, numerous other markets may continue to remain unscathed and show promising growth opportunities. In addition, supply disruption and medicine shortages of veterinary medicines had been observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine, for the treatment of COVID-19. Hence the studied market is anticipated to be impacted during the pandemic due to the reduced veterinary visits, along with the shortage of veterinary medicines, during the outbreak of COVID-19
Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-114430
Zoonotic diseases are naturally transmitted from animals to humans, due to the consumption of contaminated food and water, and exposure to the pathogen during preparation, processing, or by direct contact with infected animals or humans. Zoonotic diseases are caused by microorganisms, like viruses, bacteria, parasites, and fungi. Microbes can cause different types of diseases in humans and animals, ranging from mild to serious infections, and can even lead to death. As per the International Livestock Research Institute (ILRI) study, in India 13 zoonoses are the cause of 2.4 billion cases of human disease and 2.2 million deaths per year. Among the developing countries, India has the highest zoonotic disease burden, with widespread illness and death. Hence, owing to these factors, the market is expected to grow in the forecast period.
Key Market Trends
Vaccine Segment is Expected to have Highest Growth Rate Over the Forecasted Period
India has been in lockdown and has suspended trade with other countries and implemented travel restrictions, which has affected the import and export activities of veterinary medicines and diagnostics, leading to a decline in sales of many products. Supply disruption and medicine shortages of veterinary medicines have been observed in several regions due to the temporary lockdowns of manufacturing sites, export bans, increased demands for medicine for the treatment of COVID-19, and stockpiling of medicines by individuals. However, the government has been taking up measures to mitigate the supply of medicines and veterinary practices during the COVID-19 pandemic. For instance, in March 2020, the Government of India stated that all states must ensure that medical help for animals is treated as an essential service, which does not get suspended during COVID-19 lockdowns across the country.
Request For Full Report >>India Veterinary Healthcare Market
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
India Veterinary Healthcare Market
Minimally-invasive Surgery Devices Market
Europe Molecular Diagnostics Market
Zimbabwe Pharmaceutical Market
Bone Cancer Treatment Market
Acne Therapeutics Market
Mexico Dental Devices Market
Neurodegenerative Disease Market
Positron Emission Tomography Market
Electronic Medical Records Market
